ABSTRACT
The primary objective of this study was to estimate etravirine activities in a cohort of patients infected with non-B subtype HIV-1 and failing nevirapine based therapy.
Taiwo, B & Chaplin, B (2021). Suboptimal Etravirine Activity is Common During Failure of Nevirapine Based Combination Antiretroviral Therapy in a Cohort Infected with Non-B Subtype HIV-1. Afribary. Retrieved from https://afribary.com/works/suboptimal-etravirine-activity-is-common-during-failure-of-nevirapine-based-combination-antiretroviral-therapy-in-a-cohort-infected-with-non-b-subtype-hiv-1
Taiwo, Babafemi and Beth Chaplin "Suboptimal Etravirine Activity is Common During Failure of Nevirapine Based Combination Antiretroviral Therapy in a Cohort Infected with Non-B Subtype HIV-1" Afribary. Afribary, 01 Apr. 2021, https://afribary.com/works/suboptimal-etravirine-activity-is-common-during-failure-of-nevirapine-based-combination-antiretroviral-therapy-in-a-cohort-infected-with-non-b-subtype-hiv-1. Accessed 26 Apr. 2024.
Taiwo, Babafemi, Beth Chaplin . "Suboptimal Etravirine Activity is Common During Failure of Nevirapine Based Combination Antiretroviral Therapy in a Cohort Infected with Non-B Subtype HIV-1". Afribary, Afribary, 01 Apr. 2021. Web. 26 Apr. 2024. < https://afribary.com/works/suboptimal-etravirine-activity-is-common-during-failure-of-nevirapine-based-combination-antiretroviral-therapy-in-a-cohort-infected-with-non-b-subtype-hiv-1 >.
Taiwo, Babafemi and Chaplin, Beth . "Suboptimal Etravirine Activity is Common During Failure of Nevirapine Based Combination Antiretroviral Therapy in a Cohort Infected with Non-B Subtype HIV-1" Afribary (2021). Accessed April 26, 2024. https://afribary.com/works/suboptimal-etravirine-activity-is-common-during-failure-of-nevirapine-based-combination-antiretroviral-therapy-in-a-cohort-infected-with-non-b-subtype-hiv-1